Allergies and In-Vitro - Clinical Research Informer

Could a monoclonal antibody treat peanut allergy?

Drug Discovery World

JUNE 26, 2023

IgGenix has made advances towards a peanut allergy therapeutic based on IgG4 monoclonal antibodies. The company’s research data was presented during the 2023 European Academy of Allergy and Clinical Immunology (EAACI) Congress, in Hamburg, Germany. The post Could a monoclonal antibody treat peanut allergy?

Allergies

Allergies Antibody In-Vivo In-Vitro

Maternal Antibodies: How Allergies Can be Passed from Mothers to Children

XTalks

NOVEMBER 4, 2020

It has long been known that mothers greatly influence the development of the growing fetus by not only providing nutrients through the placenta, but also a growing list of biological elements including beneficial antibodies, gut bacteria and now, allergies. Related: Red Meat Allergy Test Gets FDA Clearance.

Allergies

Allergies Antibody In-Vitro Development

Renibus Therapeutics’ COVID-19 Treatment, RBT-9, Shows Antiviral Activity Against SARS-CoV-2 In Vitro

BioTech 365

OCTOBER 7, 2020

– Antiviral Activity Confirmed by Early Stage Studies Conducted through the National Institute of Allergy and Infectious Diseases Preclinical Services Program and Texas Biomedical Research Institute – Patient Enrollment for Phase 2 Trial Ongoing DALLAS, Texas, Oct. 07, 2020 (GLOBE … Continue reading →

In-Vitro

In-Vitro Allergies Trials Research

Antibodies from patients infected with SARS-CoV in 2003 cross-neutralized SARS-CoV-2 in vitro

Scienmag

OCTOBER 9, 2020

Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals Antibodies in serum samples collected from patients infected with SARS-CoV during the 2003 outbreak effectively neutralized SARS-CoV-2 infection in cultured cells, according to a new study.

In-Vitro

In-Vitro Antibody Allergies Medicine

Signs of healthy aging found in ergothioneine telomere study

Scienmag

DECEMBER 11, 2020

10, 2020) — An in vitro study published in theJournal of Dietary Supplements, demonstrated Blue California’s ErgoActive® ergothioneine helped to preserve telomere length and reduced the rate of telomere shortening under oxidative stress. The in vitro study is […].

In-Vitro

In-Vitro Allergies Medicine

High-fiber diet may play a role in controlling the inflammation associated with COVID-19

Scienmag

MARCH 30, 2021

In vitro treatment of cells with these molecules reduced the expression of a gene that plays a key role in viral cell entry and a cytokine receptor.

In-Vitro

In-Vitro Gene Allergies Medicine

Gilead files COVID-19 drug remdesivir with FDA

pharmaphorum

AUGUST 10, 2020

It also includes the phase 3 randomised, placebo-controlled study of Veklury conducted by the National Institute of Allergy and Infectious Diseases (NIAID). The drug is currently available to US patients under an Emergency Use Authorisation for treatment of hospitalised patients with severe COVID-19.

Drugs

Drugs In-Vivo Contract Manufacturing In-Vitro

Moderna’s COVID-19 Vaccine Effective Against New Variants

XTalks

JANUARY 27, 2021

The company used in vitro neutralization antibody studies to evaluate the activity of Moderna’s vaccine-generated antibodies in human sera against several variants of the novel coronavirus, including the B.1.1.7 The in vitro study evaluated the ability of mRNA-1273-generated antibodies to neutralize the new SARS-CoV-2 variants.

Vaccination

Vaccination Vaccine In-Vitro Protein

Tiziana announces appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer

The Pharma Data

JANUARY 12, 2021

Dr Graham is a medicines development expert and Infectious Diseases Epidemiologist with global Biotech and Pharma R&D experience in Phase I-IV therapeutics as well as in-vivo & in-vitro diagnostics, across many modalities. He has in depth Global Development Expertise (e.g. Previously, he held roles as CMO at Trimeris Inc.

Life Science

Life Science Antibody In-Vivo In-Vitro

Oyagen, Inc. Publishes Study On Its OYA1 As A “Highly Effective” Experimental Drug Candidate For Treating Infections By The Ebola Virus

The Pharma Data

JANUARY 6, 2021

In vitro studies showed that when OYA1 is dosed with remdesivir both compounds are markedly more effective inhibiting Ebola virus replication and do so at much lower doses than is needed with either compound alone. ROCHESTER, N.Y. , 7, 2021 /PRNewswire/ — OyaGen, Inc. ’ (2021) Viruses 13:52 [link]. About OYA1. OYA1 (a.k.a.

Clinical Trials

Clinical Trials Clinical Trials Drugs In-Vitro

FDA Approves Veklury (remdesivir) for the Treatment of COVID-19

The Pharma Data

OCTOBER 22, 2020

Previously authorized by the FDA for emergency use to treat COVID-19, Veklury is now the first and only approved COVID-19 treatment in the United States. The drug is now widely available in hospitals across the country, following early investments to rapidly expand manufacturing capacity to increase supply.

FDA Approval

FDA Approval Trials Clinical Trials Clinical Trials

mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends

Roots Analysis

MARCH 16, 2023

In the last few years, researchers have become interested in using in vitro transcribed (IVT) mRNA as a drug delivery agent. Messenger ribonucleic acid (mRNA) is a single-stranded molecule that is complementary to a gene’s DNA. mRNA-based therapeutics and vaccines can be delivered via the below-mentioned approaches.

Vaccination

Vaccination Vaccine DNA Protein

Pfizer Responds to Research Claims

Pfizer

JANUARY 27, 2023

and global regulatory requirements for our oral treatment, PAXLOVID™, Pfizer undertakes in vitro work (e.g., Pfizer Responds to Research Claims carterda Fri, 01/27/2023 - 19:48 Pfizer Responds to Research Claims Friday, January 27, 2023 - 08:00pm Share New York, N.Y., It is important to note that these studies are required by U.S.

Research

Research Vaccination Vaccine Drugs

Best OINTMENT or CREAM for insect bites

Druggist

FEBRUARY 17, 2021

For many customers, ointment or cream for insect bites is the first line of rescue in stings management. In this post, I will review the best ointment or cream for insect bites available over the counter and from pharmacies. I will also discuss alternative options for insect bites, mainly the use of antihistamines. 822 Reviews. £3.19.

Pharmacy

Pharmacy Containment Production Sales

Considerations for Mobile Health Technology Developers: Part 2

pharmaphorum

OCTOBER 4, 2022

Such non-device CDS are: (1) not intended to acquire, process, or analyse a medical image or a signal from an in vitro diagnostic device or a pattern or signal from a signal acquisition system (Criterion 1); (2) intended for the purpose of displaying, analysing, or printing medical information about a patient or other medical information (e.g.

Development

Development Regulation Cosmetics Life Science

Clinical Catch-Up: January 18-22 | BioSpace

The Pharma Data

JANUARY 24, 2021

It inked a deal with the National Institute of Allergy and Infectious Diseases (NIAID) to launch a Phase I trial. Brilacidin has shown in vitro to be have antiviral properties against different SARS-CoV-2 strains and other human coronaviruses. Read on to see. COVID-19-Related. It also has robust antimicrobial properties.

Trials

Trials Allergies In-Vitro Antibody

BioCryst Provides Update on Galidesivir Program

The Pharma Data

DECEMBER 21, 2020

Galidesivir has also demonstrated broad-spectrum activity in vitro against more than 20 RNA viruses in nine different families, including coronaviruses, filoviruses, togaviruses, bunyaviruses, arenaviruses, paramyxoviruses, and flaviviruses. The trial was conducted in Brazil under a U.S. investigational new drug application.

RNA

RNA Clinical Trials Clinical Trials Trials

CytoDel Announces Pre-Clinical Data on Cyto-111 as Antidote to Botulinum Neurotoxin (BoNT) Published in Science Translational Medicine

The Pharma Data

JANUARY 6, 2021

NYU Grossman School of Medicine, Department of Biochemistry and Molecular Pharmacology, who was a principal investigator in the study, which was supported by grants from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institute of Health (NIH).

Medicine

Medicine Antibody Protein In-Vitro

COVID-19 Pandemic Coverage

XTalks

SEPTEMBER 14, 2020

These companies include Moderna, a US biotech company which has formed a partnership with the National Institute of Allergy and Infectious Diseases (NIAID), Oxford University who has partnered with AstraZeneca, and Johnson & Johnson, Merck and Pfizer. The price of that prize is incalculable. Moderna’s COVID-19 Vaccine.

Vaccination

Vaccination Vaccine Antibody Life Science

Clinical Research Informer

Could a monoclonal antibody treat peanut allergy?

Maternal Antibodies: How Allergies Can be Passed from Mothers to Children

Trending Sources

Renibus Therapeutics’ COVID-19 Treatment, RBT-9, Shows Antiviral Activity Against SARS-CoV-2 In Vitro

Antibodies from patients infected with SARS-CoV in 2003 cross-neutralized SARS-CoV-2 in vitro

Signs of healthy aging found in ergothioneine telomere study

High-fiber diet may play a role in controlling the inflammation associated with COVID-19

Gilead files COVID-19 drug remdesivir with FDA

Moderna’s COVID-19 Vaccine Effective Against New Variants

Tiziana announces appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer

Oyagen, Inc. Publishes Study On Its OYA1 As A “Highly Effective” Experimental Drug Candidate For Treating Infections By The Ebola Virus

FDA Approves Veklury (remdesivir) for the Treatment of COVID-19

mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends

Pfizer Responds to Research Claims

Best OINTMENT or CREAM for insect bites

Considerations for Mobile Health Technology Developers: Part 2

Clinical Catch-Up: January 18-22 | BioSpace

BioCryst Provides Update on Galidesivir Program

CytoDel Announces Pre-Clinical Data on Cyto-111 as Antidote to Botulinum Neurotoxin (BoNT) Published in Science Translational Medicine

COVID-19 Pandemic Coverage

Stay Connected